A pan-cancer analysis of the prognostic and immunological role of β-actin (ACTB) in human cancers

References

• Sung H, Ferlay J, Bray F, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021 Feb 4;71(3):209–249.
   PubMed Web of Science ®Google Scholar
• Ferlay J, Colombet M, Soerjomataram I, et al. Cancer incidence and mortality patterns in Europe: estimates for 40 countries and 25 major cancers in 2018. Eur J Cancer. 2018;103:356–387.
   PubMed Web of Science ®Google Scholar
• Daassi D, Mahoney KM, Freeman GJ. The importance of exosomal PDL1 in tumour immune evasion. Nat Rev Immunol. 2020;20(4):209–215.
   PubMed Web of Science ®Google Scholar
• Soussi T, Wiman KG. TP53: an oncogene in disguise. Cell Death Differ. 2015;22(8):1239–1249.
   PubMed Web of Science ®Google Scholar
• Bunnell TM, Burbach BJ, Shimizu Y, et al. Beta-actin specifically controls cell growth, migration, and the G-actin pool. Mol Biol Cell. 2011;22(21):4047–4058.
   PubMed Web of Science ®Google Scholar
• Yang H, Zhang L, Liu S. Determination of reference genes for ovine pulmonary adenocarcinoma infected lung tissues using RNA-seq transcriptome profiling. J Virol Methods. 2020;284:113923.
   PubMed Web of Science ®Google Scholar
• Herath S, Dai H, Erlich J, et al. Selection and validation of reference genes for normalisation of gene expression in ischaemic and toxicological studies in kidney disease. PloS One. 2020;15(5):e0233109.
   PubMed Web of Science ®Google Scholar
• Sadek KH, Cagampang FR, Bruce KD, et al. Variation in stability of housekeeping genes in healthy and adhesion-related mesothelium. Fertil Sterility. 2012;98(4):1023–1027.
   PubMed Web of Science ®Google Scholar
• Guo C, Liu S, Wang J, et al. ACTB in cancer. Clin Chim Acta. 2013;417(2013):39–44.
   PubMedGoogle Scholar
• Liu K, Gao R, Wu H, et al. Single-cell analysis reveals metastatic cell heterogeneity in clear cell renal cell carcinoma. J Cell Mol Med. 2021:1–15. DOI:10.1111/jcmm.16479.
   PubMed Web of Science ®Google Scholar
• Riwaldt S, Bauer J, Wehland M, et al. Pathways regulating spheroid formation of human follicular thyroid cancer cells under simulated microgravity conditions: a genetic approach. Int J Mol Sci. 2016;17(4):528.
   PubMed Web of Science ®Google Scholar
• Latham SL, Ehmke, Ehmke N, et al. Variants in exons 5 and 6 of ACTB cause syndromic thrombocytopenia. Nat Commun. 2018;9(1):4250.
   PubMedGoogle Scholar
• Aleshcheva G, Wehland M, Sahana J, et al. Moderate alterations of the cytoskeleton in human chondrocytes after short-term microgravity produced by parabolic flight maneuvers could be prevented by up-regulation of BMP-2 and SOX-9. FASEB J. 2015;29(6):2303–2314.
   PubMed Web of Science ®Google Scholar
• Krzystek-Korpacka M, Diakowska D, Bania J, et al. Expression stability of common housekeeping genes is differently affected by bowel inflammation and cancer. Inflamm Bowel Dis. 2014;20(7):1147–1156.
   PubMed Web of Science ®Google Scholar
• Ben-Ze’Ev A. The cytoskeleton in cancer cells. Biochim Biophys Acta. 1985;780(3):197–212.
   PubMedGoogle Scholar
• Nowak D, Krawczenko A, Du D, et al. Actin in human colon adenocarcinoma cells with different metastatic potential. Acta Biochim Pol. 2002;52(2):461.
   Google Scholar
• Nowak D, Skwarek-Maruszewska A, Zemanek-Zboch M, et al. Beta-actin in human colon adenocarcinoma cell lines with different metastatic potential. Acta Biochim Pol. 2005;52(2):461–468.
   PubMed Web of Science ®Google Scholar
• Shestakova EA, Wyckoff J, Jones J, et al. Correlation of β-actin messenger RNA localization with metastatic potential in rat adenocarcinoma cell lines. Cancer Res. 1999;59(6):1202–1205.
   PubMed Web of Science ®Google Scholar
• Le PU, Nguyen TN, Drolet-Savoie P, et al. Increased beta-actin expression in an invasive moloney sarcoma virus-transformed MDCK cell variant concentrates to the tips of multiple pseudopodia. Cancer Res. 1998;58(8):1631–1635.
   PubMed Web of Science ®Google Scholar
• Ferguson RE, Carroll HP, Harris A, et al. Housekeeping proteins: a preliminary study illustrating some limitations as useful references in protein expression studies. Proteomics. 2005;5(2):566–571.
   PubMed Web of Science ®Google Scholar
• Gao Q, Wang XY, Fan J, et al. Selection of reference genes for real-time PCR in human hepatocellular carcinoma tissues. J Cancer Res Clin Oncol. 2008;134(9):979–986.
   PubMed Web of Science ®Google Scholar
• Fu LY, Jia HL, Dong QZ, et al. Suitable reference genes for real-time PCR in human HBV-related hepatocellular carcinoma with different clinical prognoses. BMC Cancer. 2009;9(1):49.
   PubMedGoogle Scholar
• Li Y, Ma H, Shi C, et al. Mutant ACTB mRNA 3′-UTR promotes hepatocellular carcinoma development by regulating miR-1 and miR-29a. Cell Signal. 2019;67. DOI:10.1016/j.cellsig.2019.109479.
   Web of Science ®Google Scholar
• Uhlén M, Fagerberg L, Hallström BM, et al. Proteomics. Tissue-based map of the human proteome. Sci (New York NY). 2015;347(6220):1260419.
   Google Scholar
• Uhlen M, Zhang C, Lee S, et al. A pathology atlas of the human cancer transcriptome. Sci (New York NY). 2017;357(6352):eaan2507.
   Google Scholar
• Marilyn S, Irina D, Justin A, et al. GeneCards Version 3: the human gene integrator. Database, 2010.
   Google Scholar
• Rhodes DR, Yu J, Shanker K, et al. ONCOMINE: a cancer microarray database and integrated data-mining platform. Neoplasia. 2004;6(1):1–6.
   PubMed Web of Science ®Google Scholar
• Goldman MJ, Craft B, Hastie M, et al. Visualizing and interpreting cancer genomics data via the Xena platform. Nat Biotechnol. 2020;38(6):675–678.
   PubMed Web of Science ®Google Scholar
• Tang Z, Kang B, Li C, et al. GEPIA2: an enhanced web server for large-scale expression profiling and interactive analysis. Nucleic Acids Res. 2019;47(W1):W556–w560.
   PubMed Web of Science ®Google Scholar
• Nagy Á, Munkácsy G, Győrffy B. Pancancer survival analysis of cancer hallmark genes. Sci Rep. 2021;11(6047). DOI:10.1038/s41598-021-84787-5
   Google Scholar
• Smith JJ, Deane NG, Wu F, et al. Experimentally derived metastasis gene expression profile predicts recurrence and death in patients with colon cancer. Gastroenterology. 2010 Mar;138(3):958–968.
   PubMed Web of Science ®Google Scholar
• Freeman TJ, Smith JJ, Chen X, et al. Smad4-mediated signaling inhibits intestinal neoplasia by inhibiting expression of β-catenin. Gastroenterology. 2012 Mar;142(3):562–571.e2.
   PubMed Web of Science ®Google Scholar
• Williams CS, Bernard JK, Demory Beckler M, et al. ERBB4 is over-expressed in human colon cancer and enhances cellular transformation. Carcinogenesis. 2015 Jul;36(7):710–718.
   PubMed Web of Science ®Google Scholar
• Chen MS, Lo YH, Chen X, et al. Growth factor-independent 1 is a tumor suppressor gene in colorectal cancer. Mol Cancer Res. 2019 Mar;17(3):697–708.
   PubMed Web of Science ®Google Scholar
• Pawitan Y, Bjöhle J, Amler L, et al. Gene expression profiling spares early breast cancer patients from adjuvant therapy: derived and validated in two population-based cohorts. Breast Cancer Res. 2005;7(6):R953–64.
   PubMed Web of Science ®Google Scholar
• Hall P, Ploner A, Bjöhle J, et al. Hormone-replacement therapy influences gene expression profiles and is associated with breast-cancer prognosis: a cohort study. BMC Med. 2006 Jun 30;4(1):16.
   PubMedGoogle Scholar
• Kim WJ, Kim EJ, Kim SK, et al. Predictive value of progression-related gene classifier in primary non-muscle invasive bladder cancer. Mol Cancer. 2010 Jan 8;9(1):3.
   PubMedGoogle Scholar
• Lee JS, Leem SH, Lee SY, et al. Expression signature of E2F1 and its associated genes predict superficial to invasive progression of bladder tumors. J Clin Oncol. 2010 Jun 1;28(16):2660–2667.
   PubMed Web of Science ®Google Scholar
• Li Y, Zou L, Li Q, et al. Amplification of LAPTM4B and YWHAZ contributes to chemotherapy resistance and recurrence of breast cancer. Nat Med. 2010 Feb;16(2):214–218.
   PubMed Web of Science ®Google Scholar
• Gobble RM, Qin LX, Brill ER, et al. Expression profiling of liposarcoma yields a multigene predictor of patient outcome and identifies genes that contribute to liposarcomagenesis. Cancer Res. 2011 Apr 1;71(7):2697–2705.
   PubMed Web of Science ®Google Scholar
• Freije WA, Castro-Vargas FE, Fang Z, et al. Gene expression profiling of gliomas strongly predicts survival. Cancer Res. 2004 Sep 15;64(18):6503–6510.
   PubMed Web of Science ®Google Scholar
• Chanrion M, Negre V, Fontaine H, et al. A gene expression signature that can predict the recurrence of tamoxifen-treated primary breast cancer. Clin Cancer Res. 2008 Mar 15;14(6):1744–1752.
   PubMed Web of Science ®Google Scholar
• Denkert C, Budczies J, Darb-Esfahani S, et al. A prognostic gene expression index in ovarian cancer - validation across different independent data sets. J Pathol. 2009 Jun;218(2):273–280.
   PubMed Web of Science ®Google Scholar
• Sboner A, Demichelis F, Calza S, et al. Molecular sampling of prostate cancer: a dilemma for predicting disease progression. BMC Med Genomics. 2010 Mar 16;3(1):8.
   PubMedGoogle Scholar
• Loi S, Haibe-Kains B, Desmedt C, et al. Predicting prognosis using molecular profiling in estrogen receptor-positive breast cancer treated with tamoxifen. BMC Genomics. 2008 May 22;9(1):239.
   PubMedGoogle Scholar
• Loi S, Haibe-Kains B, Majjaj S, et al. PIK3CA mutations associated with gene signature of low mTORC1 signaling and better outcomes in estrogen receptor-positive breast cancer. Proc Natl Acad Sci U S A. 2010 Jun 1;107(22):10208–10213.
   PubMed Web of Science ®Google Scholar
• Okayama H, Kohno T, Ishii Y, et al. Identification of genes upregulated in ALK-positive and EGFR/KRAS/ALK-negative lung adenocarcinomas. Cancer Res. 2012 Jan 1;72(1):100–111.
   PubMed Web of Science ®Google Scholar
• Yamauchi M, Yamaguchi R, Nakata A, et al. Epidermal growth factor receptor tyrosine kinase defines critical prognostic genes of stage I lung adenocarcinoma. PLoS One. 2012;7(9):e43923.
   PubMed Web of Science ®Google Scholar
• Mizuno H, Kitada K, Nakai K, et al. PrognoScan: a new database for meta-analysis of the prognostic value of genes. BMC Med Genomics. 2009;2(1):18.
   PubMed Web of Science ®Google Scholar
• Cerami E, Gao J, Dogrusoz U, et al. The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data. Cancer Discov. 2012;2(5):401–404.
   PubMed Web of Science ®Google Scholar
• Li T, Fu J, Zeng Z, et al. TIMER2.0 for analysis of tumor-infiltrating immune cells. Nucleic Acids Res. 2020;48(W1):W509–w14.
   PubMed Web of Science ®Google Scholar
• Racle J, Jonge KD, Baumgaertner P. Simultaneous enumeration of cancer and immune cell types from bulk tumor gene expression data. eLife, 6, e26476
   Google Scholar
• Ru B, Wong CN, Tong Y, et al. TISIDB: an integrated repository portal for tumor–immune system interactions. Bioinformatics. 2019;35(20):4200–4202.
   PubMed Web of Science ®Google Scholar
• Yuan H, Yan M, Zhang G, et al. CancerSEA: a cancer single-cell state atlas. Nucleic Acids Res. 2019 January 08;47(D1):D900–D908.
   PubMed Web of Science ®Google Scholar
• Szklarczyk D, Gable AL, Lyon D, et al. STRING v11: protein-protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets. Nucleic Acids Res. 2019Jan;47:D607–613.
   PubMed Web of Science ®Google Scholar
• Huang DW, Sherman BT, Tan Q, et al. DAVID bioinformatics resources: expanded annotation database and novel algorithms to better extract biology from large gene lists. Nucleic Acids Res. 2007;35(suppl_2):W169–75.
   PubMed Web of Science ®Google Scholar
• Prime SS, Nixon SV, Crane IJ, et al. The behaviour of human oral squamous cell carcinoma in cell culture. J Pathol. 1990 Mar;160(3):259–269.
   PubMed Web of Science ®Google Scholar
• Steven A, Seliger B. The role of immune escape and immune cell infiltration in breast cancer. Breast Care (Basel). 2018;13:16–21.
   PubMed Web of Science ®Google Scholar
• Baretti M, Le DT. DNA mismatch repair in cancer. Pharmacol Ther. 2018Sep;189:45–62.
   PubMed Web of Science ®Google Scholar
• Charoentong P, Finotello F, Angelova M, et al. Pan-cancer Immunogenomic analyses reveal genotype-immunophenotype relationships and predictors of response to checkpoint blockade. Cell Rep. 2017 Jan 3;18(1):248–262.
   PubMed Web of Science ®Google Scholar
• Saviozzi S, Cordero F, Lo Iacono M, et al. Selection of suitable reference genes for accurate normalization of gene expression profile studies in non-small cell lung cancer. BMC Cancer. 2006;6(1):200–209.
   PubMedGoogle Scholar
• Ohl F, Jung M, Xu C, et al. Gene expression studies in prostate cancer tissue: which reference gene should be selected for normalization? J Mol Med. 2005;83(12):1014–1024.
   PubMed Web of Science ®Google Scholar
• Cuvertino S, Stuart HM, Chandler KE, et al. ACTB loss-of-function mutations result in a pleiotropic developmental disorder. Am J Hum Genet. 2017 Dec 7;101(6):1021–1033.
   PubMed Web of Science ®Google Scholar
• Ben-Ze’ev A. Cytoskeletal and adhesion proteins as tumor suppressors. Curr Opin Cell Biol. 1997;9(1):99–108.
   PubMed Web of Science ®Google Scholar
• Rao J, Li N. Microfilament actin remodeling as a potential target for cancer drug development. Curr Cancer Drug Targets. 2004;4(4):345–354.
   PubMed Web of Science ®Google Scholar
• Decloitre F, Cassingena R, Estrade S, et al. Concomitant alterations of microfilaments and microtubules in human epithelial cells (HBL-100) in relation to their alignant conversion. Tumour Biol. 1991;12(2):111–119.
   PubMedGoogle Scholar
• Frontelo P, Gonzalez-Garrigues M, Vilaro S, et al. Transforming growth factor beta 1 induces squamous carcinoma cell variants with increased metastatic abilities and a disorganized cytoskeleton. Exp Cell Res. 1998;244(1):420–432.
   PubMedGoogle Scholar
• Ascierto PA, Lewis KD, Di Giacomo AM, et al. Prognostic impact of baseline tumour immune infiltrate on disease-free survival in patients with completely resected, BRAF(v600) mutation-positive melanoma receiving adjuvant vemurafenib. Ann Oncol. 2020;31(1):153–159.
   PubMed Web of Science ®Google Scholar
• Liu X, Xu J, Zhang B, et al. The reciprocal regulation between host tissue and immune cells in pancreatic ductal adenocarcinoma: new insights and therapeutic implications. Mol Cancer. 2019;18(1):184.
   PubMed Web of Science ®Google Scholar
• Wang SS, Liu W, Ly D, et al. Tumor-infiltrating B cells: their role and application in anti-tumor immunity in lung cancer. Cell Mol Immunol. 2019;16(1):6–18.
   PubMed Web of Science ®Google Scholar
• Han KQ, He XQ, Ma MY, et al. Inflammatory microenvironment and expression of chemokines in hepatocellular carcinoma. World J Gastroenterol. 2015;21(16):4864–4874.
   PubMed Web of Science ®Google Scholar
• Ying X, Liu W, Shen H, et al. Recombinant Mycobacterium bovis BCG expressing chimaeric protein of Ag85B and ESAT-6 enhances immunostimulatory activity of human macrophages. Microbes Infect. 2010 Aug;12(8–9):683–689.
   PubMed Web of Science ®Google Scholar
• Popow A, Nowak D, Malicka-Blaszkiewicz M, et al. Actin cytoskeleton and beta-actin expression in correlation with higher invasiveness of selected hepato-ma Morris 5123 cells. J Physiol Pharmacol. 2006;57(Suppl. 7):111–123.
   PubMedGoogle Scholar
• Liu K, Gao R, Wu H, et al. Single-cell analysis reveals metastatic cell heterogeneity in clear cell renal cell carcinoma. J Cell Mol Med. 2021 May;25(9):4260–4274.
   PubMed Web of Science ®Google Scholar
• Petrova DT, Brehmer F, Schultze FC, et al. Differential kidney proteome profiling in a murine model of renal fibrosis under treatment with mycophenolate mofetil. Pathobiology. 2011;78(3):162–170.
   PubMed Web of Science ®Google Scholar
• De La Fouchardiere A, Pissaloux D, Tirode F, et al. Clear cell tumor with melanocytic differentiation and ACTIN-MITF translocation: report of 7 cases of a novel entity. Am J Surg Pathol. 2020 Dec 1. DOI:10.1097/PAS.0000000000001630.
   Web of Science ®Google Scholar
• Rubie C, Kempf K, Hans J, et al. Housekeeping gene variability in normal and cancerous colorectal, pancreatic, esophageal, gastric and hepatic tissues. Mol Cell Probes. 2005;19(2):101–109.
   PubMed Web of Science ®Google Scholar
• Kheirelseid EA, Chang KH, Newell J, et al. Identification of endogenous control genes for normalisation of real-time quantitative PCR data in colorectal cancer. BMC Mol Biol. 2010;11(1):12–24.
   PubMedGoogle Scholar
• Khimani AH, Mhashilkar AM, Mikulskis A, et al. Housekeeping genes in cancer: normalization of array data. Biotechniques. 2005;38(5):739–745.
   PubMed Web of Science ®Google Scholar
• Karin M. Nuclear factor-kappaB in cancer development and progression. Nature. 2006;441(7092):431–436.
   PubMed Web of Science ®Google Scholar
• MacDonald BT, Tamai K, Xi H. Wnt/beta-catenin signaling: components, mechanisms, and diseases. Dev Cell. 2009;17(1):9–26.
   PubMed Web of Science ®Google Scholar
• Carethers JM. Intersection of transforming growth factor-β and wnt signaling pathways in colorectal cancer and metastasis. Gastroenterology. 2009;137(1):33–36.
   PubMed Web of Science ®Google Scholar
• Zhang Q, Liu Y, Chen P, et al. Solute carrier family 12 member8 (SLC12A8) is a potential biomarker and related to tumor immune cell infiltration in bladder cancer. Bioengineered. 2021;12(1):4946–4961.
   PubMed Web of Science ®Google Scholar
• Qiu H, Zhang X, Han Y, et al. Identification of potential targets of triptolide in regulating the tumor microenvironment of stomach adenocarcinoma patients using bioinformatics. Bioengineered. 2021;12(1):4304–4319.
   PubMed Web of Science ®Google Scholar
• Cui X, Zhang X, Liu M, et al. A pan-cancer analysis of the oncogenic role of staphylococcal nuclease domain-containing protein 1 (SND1) in human tumors. Genomics. 2019. DOI:10.1016/j.ygeno.2020.06.044.
   Web of Science ®Google Scholar
• Cui G, Wang C, Lin Z, et al. Prognostic and immunological role of Ras-related protein Rap1b in pan-cancer. Bioengineered. 2021;12(1):4828–4840.
   PubMed Web of Science ®Google Scholar
• Qin J, Zhanyu X, Deng K, et al. Development of a gene signature associated with iron metabolism in lung adenocarcinoma. Bioengineered. 2021;12(1):4556–4568.
   PubMed Web of Science ®Google Scholar
• Wang G, Fangfang Q, Liu S, et al. Nucleolar protein NOP2 could serve as a potential prognostic predictor for clear cell renal cell carcinoma. Bioengineered. 2021;12(1):4841–4855.
   PubMed Web of Science ®Google Scholar
• Chen F, Fan Y, Cao P, et al. Pan-cancer analysis of the prognostic and immunological role of HSF1: a potential target for survival and immunotherapy. Oxid Med Cell Longev. 2021;2021:5551036. Published 2021 Jun 18
   PubMed Web of Science ®Google Scholar